Published in Neurotox Res on September 01, 2007
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy (2014) 1.02
Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity. Toxicol Appl Pharmacol (2014) 0.90
Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease. Int J Mol Sci (2010) 0.89
Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochim Biophys Acta (2012) 0.87
Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death. J Biol Chem (2009) 0.82
Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease. Neurotox Res (2012) 0.77
Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons. Neurosci Lett (2015) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Hum Mol Genet (2012) 1.36
Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog (2010) 1.08
Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity. Neurotox Res (2014) 0.99
On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation. Neurobiol Dis (2004) 0.98
Frequency of the D620N mutation in VPS35 in Parkinson disease. Arch Neurol (2012) 0.98
Dynamin-2 function and dysfunction along the secretory pathway. Front Endocrinol (Lausanne) (2013) 0.97
Dopamine oxidation and autophagy. Parkinsons Dis (2012) 0.97
The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. Biometals (2012) 0.96
Cell lines as in vitro models for drug screening and toxicity studies. Drug Dev Ind Pharm (2005) 0.92
Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Pol J Pharmacol (2003) 0.92
Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. Toxicol Sci (2011) 0.92
Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett (2007) 0.90
Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox Res (2010) 0.90
Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review. Neurotox Res (2003) 0.89
Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome. Arch Med Res (2012) 0.88
Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol (2005) 0.88
Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. J Neurochem (2005) 0.88
Molecular and neurochemical mechanisms in PD pathogenesis. Neurotox Res (2009) 0.88
Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochim Biophys Acta (2012) 0.87
Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol (2004) 0.87
The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism. Neurotox Res (2008) 0.86
Dynamin-2 in nervous system disorders. J Neurochem (2013) 0.85
Lrrk2 mutations in South America: A study of Chilean Parkinson's disease. Neurosci Lett (2007) 0.85
Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies. Chem Res Toxicol (2007) 0.84
Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity. Chem Res Toxicol (2010) 0.83
Effect of the knockdown of amyloid precursor protein on intracellular calcium increases in a neuronal cell line derived from the cerebral cortex of a trisomy 16 mouse. Exp Neurol (2007) 0.83
Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea. Neurotox Res (2007) 0.83
Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death. J Biol Chem (2009) 0.82
Zopiclone, but not brotizolam, impairs memory storage during sleep. Neurosci Res (2003) 0.82
Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor. Pharmacol Biochem Behav (2004) 0.82
Calcium channel subtypes differentially regulate fusion pore stability and expansion. J Neurochem (2007) 0.81
Association of Parkinson disease to PARK16 in a Chilean sample. Parkinsonism Relat Disord (2010) 0.81
Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition. Chem Res Toxicol (2008) 0.80
Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Neurosci Lett (2007) 0.78
Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down syndrome. J Neurosci Res (2002) 0.78
Electrical stimulation induces calcium-dependent up-regulation of neuregulin-1β in dystrophic skeletal muscle cell lines. Cell Physiol Biochem (2012) 0.78
Sol-gel synthesis and in vitro bioactivity of copper and zinc-doped silicate bioactive glasses and glass-ceramics. Biomed Mater (2015) 0.77
Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease. Neurotox Res (2012) 0.77
Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome. Neurosci Lett (2009) 0.76
Neurotoxicological and neuroprotective elements in Parkinson's disease. Neurotox Res (2002) 0.76
Neuronal dysfunction in Down syndrome: contribution of neuronal models in cell culture. J Physiol Paris (2006) 0.75
Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America. Parkinsonism Relat Disord (2011) 0.75
Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome. J Neurosci Res (2006) 0.75
Altered voltage dependent calcium currents in a neuronal cell line derived from the cerebral cortex of a trisomy 16 fetal mouse, an animal model of Down syndrome. Neurotox Res (2011) 0.75
One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity. Neurotox Res (2013) 0.75
A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down syndrome. Neuroreport (2002) 0.75
Cell lines derived from hippocampal neurons of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function, and functional neurotransmitter receptors. Exp Neurol (2002) 0.75
Small-molecule aggregation inhibitors reduce excess amyloid in a trisomy 16 mouse cortical cell line. Biol Res (2008) 0.75
[Availability of genetic diagnosis of Huntington disease in Chile]. Rev Med Chil (2009) 0.75
Corticosterone down-regulates dopamine D4 receptor in a mouse cerebral cortex neuronal cell line. Neurotox Res (2003) 0.75
Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats. Neurotox Res (2004) 0.75